Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab
about
Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab
description
im September 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 19 September 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2018
@uk
name
Efficacy of lamivudine prophyl ...... ic SCT and receiving rituximab
@en
Efficacy of lamivudine prophyl ...... ic SCT and receiving rituximab
@nl
type
label
Efficacy of lamivudine prophyl ...... ic SCT and receiving rituximab
@en
Efficacy of lamivudine prophyl ...... ic SCT and receiving rituximab
@nl
prefLabel
Efficacy of lamivudine prophyl ...... ic SCT and receiving rituximab
@en
Efficacy of lamivudine prophyl ...... ic SCT and receiving rituximab
@nl
P2093
P50
P1433
P1476
Efficacy of lamivudine prophyl ...... ic SCT and receiving rituximab
@en
P2093
Alida Dominietto
Bianca Bruzzone
Carmen Di Grazia
Claudio Viscoli
Laura Ambra Nicolini
Patrizia Caligiuri
Teresa Lamparelli
P356
10.1007/S15010-018-1214-5
P407
P577
2018-09-19T00:00:00Z